About Us
Kayan Sahala Drug Industrial Company is a leading Saudi industrial company specialized in the development and manufacturing of pharmaceutical products and medical preparations. We are building an integrated manufacturing platform to localize pharmaceutical and medical technologies in the Kingdom.
Kayan Sahala Drug Industrial Company
Project Overview
Location: Second Industrial City, Jeddah
Land Area: 24,000 m²
Status: Industrial license obtained. Civil works for the first facility are underway.
Manufacturing Scope - Phase 1
– Tablets
– Hard Gelatin Capsules
– Semi-solids: Creams, ointments, and gels
– Additional health and nutraceutical products: planned for future expansion phases
Vision
To build a competitive Saudi pharmaceutical industrial complex with regional and global reach, combining local manufacturing, technology transfer, and world-class quality to strengthen the Kingdom’s pharmaceutical security.
Mission
To deliver high-quality, locally manufactured pharmaceutical products that meet global standards, ensure medicine availability, and build national self-sufficiency through technology transfer, innovation, and strategic partnerships.
Alignment with Saudi Vision 2030
Kayan Sahala directly supports Vision 2030 by:
1. Localizing pharmaceutical industries to reduce import dependency
2. Enhancing national drug security and supply chain resilience
3. Creating high-value jobs and developing local talent in advanced manufacturing
4. Attracting foreign investment and technology transfer to build a knowledge-based economy
Business Model
Technology transfer and strategic partnerships with leading international companies to develop local GMP-compliant manufacturing capabilities, including training and continuous technical support
Current Opportunity: Investment & Procurement
Kayan Sahala is finalizing its Master Equipment List and invites global partners and investors to collaborate on supplying equipment for production, packaging, laboratories, and supporting industrial facilities.
Chairman & Founder
Dr. Khaled Albar
At Sahala pharma, our objective is to build a Saudi-made pharmaceutical platform that earns the trust of patients and partners. By localizing advanced technologies and investing in national talent, we are strengthening the Kingdom’s medicine security and making a direct contribution to Vision 2030.
Sahala pharma was established to transform pharmaceutical self-sufficiency into reality. We are combining world-class technology with Saudi ambition to deliver high-quality medicines, made in the Kingdom, for the Kingdom and the region.
Chief Strategy Officer (CSO)
Dr. Essam Alshahaby
Our strategy is anchored in three core pillars: forging strategic global partnerships, enabling technology transfer under the highest GMP standards, and developing local capabilities.
By aligning our equipment and product portfolio with national priorities, we are building a resilient supply chain and creating high-value jobs that support the future of the pharmaceutical sector in Saudi Arabia.
Through partnerships with leading global manufacturers, we are bringing state-of-the-art technologies to Jeddah to ensure quality, scalability, and sustainable national impact in line with Vision 2030.
Committed to Perfection
We aim in Sahala Pharma to enter into collaborations to co-Develop, co-Manufacture, co-Market and to widely sell and distribute carefully selected range of products as well as under license production projects with technology transfer; relying on the huge capabilities, highest quality and unique technologies we have in KS Pharma Plant including the processing of lyophilized injectables to satisfy the ever increasing market demands in our region and across the Globe.
